question
stringlengths
47
751
answer
stringlengths
4
183
slide_id
stringlengths
23
23
project
stringclasses
1 value
f1024
stringlengths
139
139
f2048
stringlengths
138
138
f4096
stringlengths
139
139
what is the histopathological diagnosis of the tumor? A. poorly differentiated invasive solid carcinoma B. clear margins C. ductal breast carcinoma D. none of the above
A. poorly differentiated invasive solid carcinoma
TCGA-A8-A07O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_1_1024.npy
what is the resection margin status at the ventral follow-up? A. tumor-free B. infiltrated with tumor C. not specified D. unclear
A. tumor-free
TCGA-A8-A07O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212_1_1024.npy
what was the histological type of the invasive carcinoma? A. invasive ductal carcinoma B. invasive lobular carcinoma C. mucinous carcinoma D. tubular carcinoma
B. invasive lobular carcinoma
TCGA-EW-A3E8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_1024.npy
were the margins of the excised specimen positive for tumor involvement? A. yes B. no C. not applicable D. not mentioned
B. no
TCGA-EW-A3E8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_1024.npy
what was the hormone receptor status of the tumor? A. er and pr positive, her2 negative B. er positive, pr and her2 negative C. er and pr negative, her2 positive D. er, pr, and her2 negative
A. er and pr positive, her2 negative
TCGA-EW-A3E8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A3E8-01Z-00-DX1.E185B2E4-3E16-4C66-90D7-FDB9A14BA00D_1_1024.npy
what type of breast carcinoma is present? A. invasive ductal carcinoma B. invasive lobular carcinoma C. medullary carcinoma D. mucinous carcinoma
A. invasive ductal carcinoma
TCGA-EW-A1J6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_1024.npy
which receptors are positive in the tumor cells? A. estrogen receptor (er) and progesterone receptor (pr) B. her2 receptor C. androgen receptor D. epidermal growth factor receptor (egfr)
A. estrogen receptor (er) and progesterone receptor (pr)
TCGA-EW-A1J6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_1024.npy
what is the status of the her2 receptor in the tumor cells? A. negative B. positive C. not mentioned D. inconclusive
A. negative
TCGA-EW-A1J6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_1024.npy
what additional findings are mentioned in the pathology slide? A. ductal carcinoma in situ (dcis) and fibrosis with calcifications B. invasive lobular carcinoma C. metastasis to nearby lymph nodes D. benign breast tissue
A. ductal carcinoma in situ (dcis) and fibrosis with calcifications
TCGA-EW-A1J6-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A_1_1024.npy
what information about the tumor's size and extension is mentioned in the slide? A. the tumor is small in size and only locally confined. B. the tumor has extended beyond its primary location. C. the slide does not provide any information about the tumor's size and extension. D. b: the tumor has extended beyond its primary location.c: the slide does not provide any information about the tumor's size and extension.d: the tumor is large and has affected nearby structures.
C. the slide does not provide any information about the tumor's size and extension.
TCGA-C8-A12O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_1024.npy
what tests were conducted for marker tests? A. no marker tests were conducted. B. only er marker test was conducted. C. only pr marker test was conducte D. b: only er marker test was conducted.c: only pr marker test was conducted.d: marker tests for er, pr, and heer-2/neu were conducted.
D. b: only er marker test was conducted.c: only pr marker test was conducted.d: marker tests for er, pr, and heer-2/neu were conducted.
TCGA-C8-A12O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_1024.npy
what is mentioned about the histological pattern of the tumor? A. the histological pattern of the tumor is not described in the slide. B. the tumor shows a well-differentiated histological pattern. C. the tumor shows a poorly-differentiated histological pattern. D. the slide mentions multiple histological patterns observed in the tumor.
A. the histological pattern of the tumor is not described in the slide.
TCGA-C8-A12O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_1024.npy
what is mentioned about the cellular differentiation and nuclear grade of the tumor? A. the tumor shows high cellular differentiation and low nuclear grade. B. the tumor shows low cellular differentiation and high nuclear grade. C. the slide does not provide any information about cellular differentiation and nuclear grade. D. the tumor shows high cellular differentiation and high nuclear grade.
C. the slide does not provide any information about cellular differentiation and nuclear grade.
TCGA-C8-A12O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_1024.npy
what is mentioned in the microscopic appearance section of the slide? A. the slide does not have a microscopic appearance section. B. the microscopic appearance section describes the tumor's cellular distribution and structural patterns. C. the microscopic appearance section describes the tumor's mitotic rate. D. the microscopic appearance section provides information about the tumor's metastatic potential.
B. the microscopic appearance section describes the tumor's cellular distribution and structural patterns.
TCGA-C8-A12O-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C_1_1024.npy
what type of changes are observed in the non-neoplastic breast tissue? A. proliferative fibrocystic changes B. nonproliferative fibrocystic changes C. proliferative changes D. malignant changes
B. nonproliferative fibrocystic changes
TCGA-AR-A24Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_1_1024.npy
what further analysis has been ordered on the tissue samples? A. estrogen and progesterone receptor status B. her2/neu expression C. nottingham score D. axillary sentinel lymph nodes
A. estrogen and progesterone receptor status
TCGA-AR-A24Z-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46_1_1024.npy
what are the findings from the margins of excision in the breast? A. no evidence of cancer B. invasive carcinoma C. dcis mixed with invasive carcinoma D. benign breast tissue.
D. benign breast tissue.
TCGA-AO-A0J4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_1024.npy
what are the findings from the palpable mass biopsy in the breast? A. no evidence of cancer B. invasive carcinoma C. dcis mixed with invasive carcinoma D. benign breast tissue.
C. dcis mixed with invasive carcinoma
TCGA-AO-A0J4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_1024.npy
what additional testing is pending to determine the extent of invasion? A. lymph nodes B. margins of excision C. palpable mass biopsy D. skeletal metastasis
C. palpable mass biopsy
TCGA-AO-A0J4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_1024.npy
what does the slide mention about skeletal metastasis? A. no evidence of cancer B. invasive carcinoma C. dcis mixed with invasive carcinoma D. the slide does not mention skeletal metastasis.
B. invasive carcinoma
TCGA-AO-A0J4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_1024.npy
what is the overall indication from the slide? A. need for further evaluation and treatment B. no evidence of cancer C. invasive carcinoma D. dcis mixed with invasive carcinoma
A. need for further evaluation and treatment
TCGA-AO-A0J4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8_1_1024.npy
what were the other findings? A. metastatic carcinoma with extranodal extension B. high nuclear grade ductal carcinoma in situ C. negative margins and a modified scarff bloom richardson grade of 2 D. negative for tumor
B. high nuclear grade ductal carcinoma in situ
TCGA-E2-A1LA-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1LA-01Z-00-DX1.AE49E943-B830-4ED9-B09E-E499441BC2EC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1LA-01Z-00-DX1.AE49E943-B830-4ED9-B09E-E499441BC2EC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1LA-01Z-00-DX1.AE49E943-B830-4ED9-B09E-E499441BC2EC_1_1024.npy
what was the grade of the infiltrating ductal carcinoma? A. nottingham grade ii B. nottingham grade i C. nottingham grade iii D. nottingham grade iv
C. nottingham grade iii
TCGA-AR-A0U0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_1024.npy
what type of breast surgery did the patient have? A. lumpectomy B. simple mastectomy C. modified radical mastectomy D. axillary dissection
B. simple mastectomy
TCGA-AR-A0U0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_1024.npy
what were the results of the surgical margins? A. positive B. negative C. indeterminate D. not mentioned
B. negative
TCGA-AR-A0U0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_1024.npy
what were the findings in the remaining breast tissue? A. fibrocystic change, ductal hyperplasia, apocrine metaplasia B. fibroadenoma, lobular carcinoma in situ, papillary carcinoma C. fibroadenoma, adenoid cystic carcinoma, intraductal papilloma D. atypical ductal hyperplasia, phyllodes tumor, granulomatous mastitis
A. fibrocystic change, ductal hyperplasia, apocrine metaplasia
TCGA-AR-A0U0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_1024.npy
were the estrogen and progesterone receptors positive or negative? A. positive B. negative C. not mentioned D. inconclusive
B. negative
TCGA-AR-A0U0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6_1_1024.npy
what is the final diagnosis mentioned in the pathological slide? A. "taprliaating ductal akel2on, cbt ampnane metastasized to w2b, g-4 ln" B. "invasive lobular carcinoma, with no metastasis" C. "ductal carcinoma in situ, with lymph node metastasis" D. "metaplastic carcinoma, with distant metastasis"
A. "taprliaating ductal akel2on, cbt ampnane metastasized to w2b, g-4 ln"
TCGA-C8-A12Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_1024.npy
what are the cellular features mentioned in the slide? A. not mentioned in the slide B. nuclear grade C. microscopic appearance D. histological patterns
A. not mentioned in the slide
TCGA-C8-A12Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_1024.npy
what is the nuclear grade mentioned in the slide? A. not mentioned in the slide B. grade 4 C. grade 3 D. grade 2
B. grade 4
TCGA-C8-A12Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_1024.npy
what is the histological pattern mentioned in the slide? A. not mentioned in the slide B. invasive lobular carcinoma C. metaplastic carcinoma D. ductal carcinoma in situ
A. not mentioned in the slide
TCGA-C8-A12Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3_1_1024.npy
what type of breast cancer has the patient been diagnosed with? A. infiltrative ductal carcinoma B. infiltrative lobular carcinoma C. infiltrative papillary carcinoma D. infiltrative medullary carcinoma
A. infiltrative ductal carcinoma
TCGA-AN-A0XU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_1024.npy
what is the grade of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4
C. grade 3
TCGA-AN-A0XU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_1024.npy
has the cancer spread to distant sites? A. yes B. no C. not mentioned D. can't be determined
B. no
TCGA-AN-A0XU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_1024.npy
has the patient received any treatment yet? A. yes B. no C. not mentioned D. can't be determined
B. no
TCGA-AN-A0XU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F_1_1024.npy
what are the patient's chief complaints? A. pain and weight gain B. dizziness and shortness of breath C. fever and cough D. anxiety and insomnia
A. pain and weight gain
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
what are the positive lab results shown in the slide? A. cea, ca 153, ca 19-9, and psa B. tb, hiv, mrsa, and e.coli C. alt, ast, bun, and creatinine D. hba1c, ldl, hdl, and triglycerides
A. cea, ca 153, ca 19-9, and psa
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
which diagnostic studies were conducted on the patient? A. ultrasound, x-ray, endoscopy, and mri B. ct scan, eeg, colonoscopy, and bone scan C. gastric emptying study, ekg, bronchoscopy, and pet scan D. bone marrow biopsy, skin biopsy, angiography, and mammogram
A. ultrasound, x-ray, endoscopy, and mri
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
what treatment was performed on the patient? A. surgical treatment B. chemotherapy C. radiation therapy D. physical therapy
A. surgical treatment
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
what was administered to the patient before surgery? A. neoadjuvant therapy B. palliative care C. complementary and alternative medicine D. immunotherapy
A. neoadjuvant therapy
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
what aspect of the pathology slide is not provided in the summary? A. pathological description of the primary tumor B. pathological description of lymph nodes C. pathological description of distant metastasis D. all of the above
D. all of the above
TCGA-C8-A26X-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242_1_1024.npy
what type of carcinoma has the patient been diagnosed with? A. poorly differentiated invasive ductal carcinoma B. well differentiated invasive lobular carcinoma C. moderately differentiated invasive ductal carcinoma D. poorly differentiated invasive lobular carcinoma
A. poorly differentiated invasive ductal carcinoma
TCGA-A8-A075-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_1024.npy
what is the grade of the tumor? A. grade i B. grade ii C. grade iii D. grade iv
C. grade iii
TCGA-A8-A075-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_1024.npy
what is the pt stage of the tumor? A. pt1 B. pt2 C. pt3 D. pt4
B. pt2
TCGA-A8-A075-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_1024.npy
what is the n stage of the tumor? A. n0 B. n1 C. n2 D. n3
B. n1
TCGA-A8-A075-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_1024.npy
what is the presence or absence of vascular invasion? A. no vascular invasion B. focal vascular invasion C. extensive vascular invasion D. distant vascular invasion
B. focal vascular invasion
TCGA-A8-A075-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F_1_1024.npy
what was the reason for the patient's mastectomy? A. ductal carcinoma in situ (dcis) B. invasive ductal carcinoma C. adenoid cystic carcinoma D. apocrine metaplasia
B. invasive ductal carcinoma
TCGA-E2-A15T-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_1024.npy
what is the grade of the invasive ductal carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-E2-A15T-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_1024.npy
what type of carcinoma is mixed with the invasive carcinoma in the upper outer quadrant of the breast? A. lobular carcinoma in situ (lcis) B. ductal carcinoma in situ (dcis) C. medullary carcinoma D. metaplastic carcinoma
B. ductal carcinoma in situ (dcis)
TCGA-E2-A15T-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A_1_1024.npy
what is the type of carcinoma indicated in the slide? A. infiltrating ductal carcinoma B. infiltrating lobular carcinoma C. mucinous carcinoma D. paget's disease of the nipple
A. infiltrating ductal carcinoma
TCGA-E9-A248-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_1024.npy
what is the histologic grade of the tumor? A. cannot be determined B. well differentiated C. moderately differentiated D. poorly differentiated
D. poorly differentiated
TCGA-E9-A248-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_1024.npy
are the margins of the specimen involved? A. no B. yes C. not mentioned D. cannot be determined
A. no
TCGA-E9-A248-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_1024.npy
is there any information about neo-adjuvant treatment? A. no B. yes C. not mentioned D. cannot be determined
A. no
TCGA-E9-A248-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1_1_1024.npy
what was the surgical procedure performed? A. lumpectomy B. hysterectomy C. mastectomy D. appendectomy
C. mastectomy
TCGA-EW-A1IX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_1024.npy
what is the grade of the invasive tubulolobular carcinoma? A. high nuclear grade B. low nuclear grade C. intermediate nuclear grade D. unknown nuclear grade
B. low nuclear grade
TCGA-EW-A1IX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_1024.npy
what is the immunophenotype of the tumor cells? A. positive for estrogen receptor and progesterone receptor, negative for her2 B. negative for estrogen receptor and progesterone receptor, positive for her2 C. positive for estrogen receptor, progesterone receptor, and her2 D. negative for estrogen receptor, progesterone receptor, and her2
A. positive for estrogen receptor and progesterone receptor, negative for her2
TCGA-EW-A1IX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_1024.npy
did the slide mention the presence of microcalcifications? A. yes B. no C. cannot determine D. not mentioned
A. yes
TCGA-EW-A1IX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_1024.npy
were the resection margins free of tumor? A. yes B. no C. cannot determine D. not mentioned
A. yes
TCGA-EW-A1IX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1IX-01Z-00-DX1.72AE0E0F-B213-454F-8275-76A7C43FAB86_1_1024.npy
what type of carcinoma is found in the breast mastectomy specimen? A. invasive ductal carcinoma B. invasive lobular carcinoma C. invasive papillary carcinoma D. invasive adenocarcinoma
B. invasive lobular carcinoma
TCGA-GM-A4E0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_1024.npy
what is the presence of lymphovascular invasion in the breast mastectomy specimen? A. not identified B. focal signet ring cell features C. extensive lymphovascular invasion D. inconclusive
A. not identified
TCGA-GM-A4E0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_1024.npy
what is the presence of invasive carcinoma near the inferior margin in the breast mastectomy specimen? A. no invasive carcinoma B. focal signet ring cell features C. extensive invasive carcinoma D. small focus of invasive carcinoma
D. small focus of invasive carcinoma
TCGA-GM-A4E0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A4E0-01Z-00-DX1.55A5D765-AA35-4052-9185-6872B580F0F6_1_1024.npy
what staining method was used to examine the sentinel node blocks? A. h&e stained immunostains B. criteria for positive results C. gross description of the specimens D. size and characteristics of the lymph nodes
D. size and characteristics of the lymph nodes
TCGA-AC-A3HN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_1024.npy
what does the addendum provide additional information about? A. gross description of the left breast specimen B. methods and criteria for positive results C. size and characteristics of the tumor D. presence of a biopsy site in the lymph nodes
D. presence of a biopsy site in the lymph nodes
TCGA-AC-A3HN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_1024.npy
what is mentioned about the deep margin? A. size and characteristics of the tumor B. presence of a hemorrhagic biopsy site C. methods and criteria for positive results D. status of the deep margin
D. status of the deep margin
TCGA-AC-A3HN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_1024.npy
what type of cancer is described in the slide? A. left breast cancer B. metastatic mammary carcinoma C. micrometastatic mammary carcinoma D. tumor negative lymph nodes
D. tumor negative lymph nodes
TCGA-AC-A3HN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A3HN-01Z-00-DX1.1AA71B9B-1B61-41A9-91CF-B7649DEC189E_1_1024.npy
what is the grade of the tumor? A. 1 out of 3 B. 2 out of 3 C. 3 out of 3 D. 4 out of 5
B. 2 out of 3
TCGA-LL-A5YL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_1024.npy
what type of breast cancer did the patient have? A. ductal carcinoma in situ B. invasive lobular carcinoma C. metastatic carcinoma D. lobular carcinoma in situ
B. invasive lobular carcinoma
TCGA-LL-A5YL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_1024.npy
what is the status of er in the tumor? A. positive B. negative C. not mentioned D. partially positive
A. positive
TCGA-LL-A5YL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_1024.npy
what is the status of pr in the tumor? A. positive B. negative C. not mentioned D. partially positive
B. negative
TCGA-LL-A5YL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-LL-A5YL-01Z-00-DX1.164C74AB-87D5-46CC-9D96-33FE1F88DC80_1_1024.npy
what is the nottingham score for the tumor? A. 6/9 B. 3/7 C. 2/5 D. 4/6
A. 6/9
TCGA-BH-A0BR-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_1024.npy
is there lymphovascular space involvement? A. yes B. no C. cannot be determined D. not mentioned
B. no
TCGA-BH-A0BR-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_1024.npy
what is the predominant type of in situ tumor? A. solid and comedo B. invasive ductal C. ductal carcinoma in situ D. ibriform and solid types
A. solid and comedo
TCGA-BH-A0BR-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_1024.npy
what is the score for her2/neu? A. 0 or 1+ B. 3+ C. 2+ D. 4+
A. 0 or 1+
TCGA-BH-A0BR-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF_1_1024.npy
what type of cancer did the patient have in the breast? A. invasive ductal carcinoma B. invasive lobular carcinoma C. lobular carcinoma in situ D. mammatome biopsy
B. invasive lobular carcinoma
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
what is the histologic grade of the invasive lobular carcinoma? A. high histologic grade B. intermediate histologic grade C. low histologic grade D. undetermined histologic grade
C. low histologic grade
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
what is the evidence of spreading within the milk ducts called? A. invasive carcinoma B. pagetoid spread C. metastasis D. lobular carcinoma in situ
B. pagetoid spread
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
what is the overall diagnosis of the patient? A. invasive ductal carcinoma of the right breast B. invasive lobular carcinoma of the left breast C. ductal carcinoma in situ D. metastatic carcinoma
B. invasive lobular carcinoma of the left breast
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
which immunohistochemical examination showed a negative reaction? A. ki67 proliferation antigen B. e-cadherin C. ck7 D. neoplastic cells
B. e-cadherin
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
what is the recommended action for the patient based on the slide? A. undergo a second biopsy B. complete a radiation therapy C. start chemotherapy treatment D. contact their doctor
D. contact their doctor
TCGA-D8-A1XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1XO-01Z-00-DX1.A9EF6AFF-62B0-4E2D-ABC7-DC06FF473890_1_1024.npy
what is the sbr grade of the invasive ductal carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
A. grade 1
TCGA-E2-A1B4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_1_1024.npy
what are the marker proteins used to identify the foci of intraductal papilloma? A. p63 and calponin B. her2 and egfr C. er and pr D. ki-67 and p53
A. p63 and calponin
TCGA-E2-A1B4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C_1_1024.npy
what was the grade of the invasive lobular carcinoma? A. grade i. B. grade ii. C. grade iii. D. grade iv.
C. grade iii.
TCGA-PE-A5DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_1024.npy
was the tumor found in the final inferior margin excision? A. yes. B. no. C. the slide does not mention this. D. the slide is unclear.
B. no.
TCGA-PE-A5DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_1024.npy
was the excised tissue from the final inferior margin evaluated? A. yes. B. no. C. the slide does not mention this. D. the slide is unclear.
A. yes.
TCGA-PE-A5DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_1024.npy
were there any positive margins in the lumpectomy specimen? A. all margins were positive. B. only the anterior margin was positive. C. no margins were positive. D. the slide is unclear.
C. no margins were positive.
TCGA-PE-A5DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-PE-A5DC-01Z-00-DX1.8E6953AD-C14A-43F5-B062-E31AB13C7BDF_1_1024.npy
what is the final diagnosis of the tumor? A. benign breast tumor B. invasive ductal carcinoma C. lipoma D. breast abscess
B. invasive ductal carcinoma
TCGA-A2-A0CM-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_1024.npy
what is the grade of the cancer according to the modified bloom richardson grading system? A. grade i/iii B. grade ii/iii C. grade iii/iii D. grade iv/iii
C. grade iii/iii
TCGA-A2-A0CM-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_1024.npy
what is the result of estrogen receptor testing? A. positive B. negative C. weakly positive D. strongly positive
B. negative
TCGA-A2-A0CM-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_1024.npy
is her2/neu protein associated with the tumor? A. yes B. no C. the slide doesn't mention D. it's unclear
B. no
TCGA-A2-A0CM-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_1024.npy
what is the condition of the surrounding tissue? A. cancerous B. slightly cancerous C. fatty and unremarkable D. fibrous and unremarkable
C. fatty and unremarkable
TCGA-A2-A0CM-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828_1_1024.npy
what grade is the lobular carcinoma in situ? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-A7-A4SA-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_1024.npy
is there evidence of vessel invasion? A. yes B. no C. unclear D. not mentioned
B. no
TCGA-A7-A4SA-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_1024.npy
are all surgical margins negative for the breast tumor? A. yes B. no C. partially negative D. not mentioned
A. yes
TCGA-A7-A4SA-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_1024.npy
is there ductal carcinoma in situ identified? A. yes B. no C. insufficient information D. not mentioned
B. no
TCGA-A7-A4SA-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SA-01Z-00-DX1.B48FFD3E-9B45-4CEA-ACEE-5B08058CCF5F_1_1024.npy
what is the tumor classified as based on the histological findings? A. polymorphocellular variant of invasive lobular breast carcinoma B. ductal carcinoma in situ C. medullary carcinoma D. invasive ductal carcinoma
A. polymorphocellular variant of invasive lobular breast carcinoma
TCGA-A8-A0A7-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_1024.npy
what is the tumor classification according to the ptnm system? A. g ii, pt2pn1a(1/14)l1voro B. g i, pt1pn0(0/4)l0voro C. g iii, pt3pn2a(3/6)l2voro D. g ii, pt2pn0(0/12)l1voro
A. g ii, pt2pn1a(1/14)l1voro
TCGA-A8-A0A7-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_1024.npy
is the tumor positive for estrogen and progesterone receptors? A. no B. yes C. insufficient data D. not mentioned
A. no
TCGA-A8-A0A7-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_1024.npy
what is the c-erb b-2 oncoprotein status of the tumor? A. positive B. negative C. insufficient data D. not mentioned
A. positive
TCGA-A8-A0A7-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A8-A0A7-01Z-00-DX1.A0FD4EEF-B536-47C1-BDA1-7AC71BA3E978_1_1024.npy
what is the diagnosis for the samples collected from the patient? A. ovarian cyst B. breast cancer C. diabetes D. meningitis
B. breast cancer
TCGA-OL-A6VO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_1_1024.npy
what is the histologic grade of the invasive ductal carcinoma? A. i B. ii C. iii D. iv
C. iii
TCGA-OL-A6VO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014_1_1024.npy